Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 14, 2001

View Archived Issues

New Target For Thrombotic Drugs Could Increase Safety

Genset Cuts Back Genomics Focus, Moves On To Discovery

British Biotech's Marimistat Fails In Promising Indication

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Despite Resistance In France, Chirac Sees Place For GM Crops

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Curacyte Gets Into Full Swing With US$6.5M Seed Financing

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

French Advancing Legislation To Allow Therapeutic Cloning

Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs

Medica Strengthens Position With Kinase-Targeting Filings

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...